Evidence map›Paper›PMID 9761742›Full record

ArticleThe Biochemical journal1998

Atypical protein kinase Clambda binds and regulates p70 S6 kinase.

K Akimoto, M Nakaya, T Yamanaka, J Tanaka, S Matsuda, Q P Weng, J Avruch, S Ohno

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Mechano-transduction to muscle protein synthesis is modulated by FAK.European journal of applied physiology · 2009
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Natural biology of polyomavirus middle T antigen.Microbiology and molecular biology reviews : MMBR · 2001
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

K AkimotoDepartment of Molecular Biology, Yokohama City University School of Medicine, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236, Japan.
M Nakaya
T Yamanaka
J Tanaka
S Matsuda
Q P Weng
J Avruch
S Ohno
Yokohama City University · JP

Funding

PHOSPHOPEPTIDE METABOLISM IN ADIPOCYTESR37DK017776 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI AVRUCH, JOSEPH · 1999 to 2018
$9.3M
PHOSPHOPEPTIDE METABOLISM IN ADIPOCYTESR01DK017776 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI AVRUCH, JOSEPH · 1986 to 1998
–
NIDDK NIH HHS DK17776
6 · The paper itself

Abstract

p70 S6 kinase (p70 S6K) has been implicated in the regulation of cell cycle progression. However, the mechanism of its activation is not fully understood. In the present work, evidence is provided that an atypical protein kinase C (PKC) isotype, PKClambda, is indispensable, but not sufficient, for the activation of p70 S6K. Both the regulatory and kinase domains of PKClambda associate directly with p70 S6K. Overexpression of the kinase domain without kinase activity or the regulatory domain of PKClambda results in the suppression of the serum-induced activation of p70 S6K. In addition, two types of dominant-negative mutants of PKClambda, as well as a kinase-deficient mutant of p70 S6K, suppress serum-induced DNA synthesis and E2F activation. The overexpresion of the active form of PKClambda, however, fails to activate p70 S6K. These results suggest that PKClambda is a mediator in the regulation of p70 S6K activity and plays an important role in cell cycle progression.

Indexed as

Carrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsAmino Acid SequenceAnimalsCell CycleE2F Transcription FactorsEnzyme ActivationGene Expression RegulationHumansIsoenzymesMolecular Sequence DataMutationPlatelet-Derived Growth FactorProtein Kinase CProtein Kinase C-lambdaCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsE2F Transcription FactorsIsoenzymesPlatelet-Derived Growth FactorProtein Kinase CProtein Kinase C-lambdaRetinoblastoma-Binding Protein 1Ribosomal Protein S6 KinasesSirolimusTranscription Factor DP1Transcription Factors

Identifiers

PMID9761742
PMCPMC1219797
OpenAlexW2338819470

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.